Aztiq

Aztiq company information, Employees & Contact Information

Explore related pages

Related company profiles:

Aztiq is a long-term investment fund, based in Iceland, focused on pharmaceuticals, real estate, arts & culture, and numerous community projects in Iceland and internationally. See Icelandic below. The shareholder base consists of individual investors, as well as large international investment funds. https://aztiqfinance.com/ Aztiq’s largest assets are pharmaceutical companies Alvogen and Alvotech and the real estate company Saemundur. Aztiq is in the process of constructing a high-tech biologic center in the UI (University of Iceland) Science Park in Vatnsmyri, Reykjavik, which will double the size of the fund’s pharmaceutical facilities in Iceland. Additionally, Aztiq is a major shareholder in Þorpið (reads Thorpid) – an ecological community development project, in partnership with the City of Reykjavik. Aztiq's shareholder base consists of individual investors, led by Robert Wessman, as well as large international investment funds. Icelandic: Aztiq er virkur langtímafjárfestir hérlendis sem erlendis, meðal annars í lyfjaiðnaði, fasteignum, menningarauði og samfélagsverkefnum. Fjárfestingarhópur Aztiq saman stendur af öflugum íslenskum og erlendum einstaklingum sem og alþjóðlegum fjárfestingarsjóðum undir stjórn Róberts Wessman. Stærstu eignir Aztiq eru í lyfjafyrirtækjunum Alvogen, Alvotech, Lotus, Almatica og Adalvo og í fasteignafélögunum Hrjáf, Sæmundi og Eyjólfi. Astiq stendur að uppbyggingu hátækniseturs í Vatnsmýri en áætluð verklok eru í árslok 2022. Þá er Aztiq stór hluthafi í Þorpinu – vistfélagi í samstarfi við Reykjavíkurborg.

Company Details

Employees
15
Founded
-
Address
Reykjavik, Is
Industry
Investment Management
NAICS
Other Financial Investment Activities
Portfolio Management
All Other Financial Investment Activities
Trust, Fiduciary, and Custody Activities
Miscellaneous Financial Investment Activities
HQ
Reykjavik
Looking for a particular Aztiq employee's phone or email?

Aztiq Questions

News

Aztiq sells Adalvo to EQT - GlobeNewswire

Aztiq sells Adalvo to EQT GlobeNewswire

Aztiq Consulting ehf. - Via Ritzau

Aztiq Consulting ehf. Via Ritzau

Malta: EQT agrees to acquire Adalvo from Aztiq to drive next growth phase - Investors in Healthcare

Malta: EQT agrees to acquire Adalvo from Aztiq to drive next growth phase Investors in Healthcare

Adalvo Changes Hands As EQT Takes Control - Citeline News & Insights

Adalvo Changes Hands As EQT Takes Control Citeline News & Insights

Alvogen Lux Holdings Acquires 210,000 Shares in Alvotech at ISK 1,277.38 - Quiver Quantitative

Alvogen Lux Holdings Acquires 210,000 Shares in Alvotech at ISK 1,277.38 Quiver Quantitative

Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse - PR Newswire

Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse PR Newswire

Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse - PR Newswire

Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse PR Newswire

Innobic, Aztiq acquire Lotus Pharmaceutical, Adalvo for $475m, eye emerging Asean markets - Nation Thailand

Innobic, Aztiq acquire Lotus Pharmaceutical, Adalvo for $475m, eye emerging Asean markets Nation Thailand

Alvo Group Opens London Offices - Citeline News & Insights

Alvo Group Opens London Offices Citeline News & Insights

Top Aztiq Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant